Register April 2011 No. 664
Chapter CSB 2
ADDITIONS TO SCHEDULES IN SS. 961.14,
961.16, 961.18, 961.20 AND 961.22, STATS.
CSB 2.01 Addition of methaqualone to schedule II.
CSB 2.02 Addition of benzphetamine, chlorphentermine, clortermine, mazindol, and phendimetrazine to schedule III.
CSB 2.03 Addition of fenfluramine to schedule IV.
CSB 2.04 Addition of amobarbital, pentobarbital, and secobarbital to schedule II; retention of certain forms of amobarbital, pentobarbital and secobarbital in schedule III.
CSB 2.05 Addition of drotebanol to schedule I.
CSB 2.06 Addition of pentazocine to schedule III.
CSB 2.07 Transfer of hydrochloride form of etorphine from schedule I to schedule II.
CSB 2.08 Addition of poppy straw to schedule II, addition of pemoline and mebutamate to schedule IV.
CSB 2.09 Additions to schedules IV and I.
CSB 2.10 Addition of propiram to schedule I.
CSB 2.11 Renumbering and addition to schedule IV of diethylpropion and phentermine.
CSB 2.13 Addition of dextropropoxyphene to schedule IV.
CSB 2.14 Addition of prazepam to schedule IV.
CSB 2.15 Addition of parahexyl to schedule I; removal of loperamide from schedule V; addition of triazolam to schedule IV.
CSB 2.16 Transfer of sufentanil from schedule I to schedule II.
CSB 2.17 Addition of buprenorphine to schedule V; transfer of methaqualone from schedule II to schedule I; transfer of dronabinol from schedule I to schedule II.
CSB 2.18 Addition of 3,4-methylenedioxymethamphetamine to schedule I.
CSB 2.19 Additions, deletions and transfers to statutory schedules.
CSB 2.20 Addition of beta-hydroxy-3-methylfentanyl to schedule I.
CSB 2.21 Additions, deletions, corrections, transfers, and amendments to drug schedules.
CSB 2.22 Additions to drug schedules.
CSB 2.23 Additions and amendments to drug schedules.
CSB 2.24 Addition of butorphanol to schedule IV.
CSB 2.25 Addition of remifentanil to schedule II; transfer of dronabinol from schedule II to schedule III; addition of fenproporex, modafinil, sibutramine, zaleplon and zolpidem to schedule IV; spelling correction of carfentanil.
CSB 2.26 Addition of dihydroetorphine to schedule II.
CSB 2.28 Addition of dichloralphenazone to schedule IV.
CSB 2.29 Transfer of buprenorphine from schedule V to schedule III.
CSB 2.30 Addition of gamma-hydroxybutyric acid to schedule III.
CSB 2.31 Addition of 2,5 dimethoxy-4-(n)- propylthiophenethylamine (2C-T-7) to schedule I.
CSB 2.32 Addition of N- benzylpiperazine (BZP) to schedule I.
CSB 2.33 Addition of alpha-methyltryptamine (AMT) to schedule I.
CSB 2.34 Addition of 5-methoxy-N, N-diisopropyltryptamine (5-MeO-DIPT).
CSB 2.35 Addition of lisdexamfetamine to schedule II.
CSB 2.01
CSB 2.01
Addition of methaqualone to schedule II. The substance known as methaqualone is hereby added to s.
161.16, Stats., schedule II in sub. (6) which subsection is hereby created.
CSB 2.01 History
History:
Cr.
Register, June, 1973, No. 210, eff. 7-1-73.
CSB 2.02
CSB 2.02
Addition of benzphetamine, chlorphentermine, clortermine, mazindol, and phendimetrazine to schedule III. The substances known as benzphetamine, chlorphentermine, clortermine, mazindol, and phendimetrazine are hereby added to
s. 161.18, Stats., schedule III in sub. (2m) (a), (b), (c), (d) and (e) respectively, which subsections are created to read:
(2m) Any material, compound, mixture, or preparation which contains any quantity of the following substances having a potential for abuse associated with a stimulant effect on the central nervous system:
(a) Benzphetamine
(b) Chlorphentermine
(c) Clortermine
(d) Mazindol
(e) Phendimetrazine
CSB 2.02 History
History:
Cr.
Register, October, 1973, No. 214, eff. 11-1-73.
CSB 2.03
CSB 2.03
Addition of fenfluramine to schedule IV. The substance known as fenfluramine is hereby added to
s. 161.20, Stats., schedule IV in sub. (2m) (a), which subsection is hereby created to read:
(2m) Any material, compound, mixture, or preparation which contains any quantity of the following substances having a potential for abuse associated with a stimulant effect on the central nervous system:
(a) Fenfluramine:
CSB 2.03 History
History:
Cr.
Register, October, 1973, No. 214, eff. 11-1-73.
CSB 2.04
CSB 2.04
Addition of amobarbital, pentobarbital, and secobarbital to schedule II; retention of certain forms of amobarbital, pentobarbital and secobarbital in schedule III. CSB 2.04(1)(1)
Subsection (7) of s. 161.16, Stats., schedule II is hereby created to read as follows:
(7) Unless excepted under federal regulations or listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances:
(a) Amobarbital
(b) Pentobarbital
(c) Secobarbital